Mobidiag Ltd.

"Mobidiag Ltd. is a commercial stage, fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Healthcare Associated Infections (HAIs), Respiratory Infections and Sepsis.

Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and instruments: Novodiag® (on-demand testing) and Amplidiag® (high-throughput, batch testing). These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.

Mobidiag Ltd. is headquartered in Espoo, Finland, with subsidiaries in France, United Kingdom and Sweden.